Open AccessFirst Report of SARS-CoV-2 Lineage B.1.1.7 (Alpha Variant) in Ecuador, January 2021
Author(s) -
Andrés Carrazco-Montalvo,
Alfredo Bruno,
Doménica de Mora,
Maritza Olmedo,
Jimmy Garcés,
Michelle Paez,
Mary Regato-Arrata,
M Ajenjo González,
J. Delgado Romero,
Orson Mestanza,
Byron FreirePaspuel,
A. Gaviria,
Solon-Alberto Orlando,
Miguel Ángel García-Bereguiain,
Leandro Patiño
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s319439
Subject(s) - lineage (genetic) , contact tracing , covid-19 , transmission (telecommunications) , whole genome sequencing , genome , alpha (finance) , geography , biology , virology , genealogy , evolutionary biology , medicine , genetics , history , gene , computer science , outbreak , telecommunications , infectious disease (medical specialty) , disease , surgery , construct validity , patient satisfaction
On January 5 2021, Ecuadorian COVID-19 genomic surveillance program detected a suspicious case of the B.1.1.7 lineage (alpha variant) of SARS-CoV-2 in Los Rios province, later confirmed by genome sequencing. The patient travelled from the UK by the end of December 2020. By contact tracing, several new cases were detected confirming B.1.1.7 transmission and spreading in Ecuador.